If only. Pretty sure mike's solution involves genocide of some sort. Because he's so ballzy.
Allow me. Extreme narcicism, nihilism, depressive disorder, chronic underachievement, and utter disdain for humanity. He's a rock.
You on medical weed? Many stocks are lighting it up with big beats and market breadth is hanging right at all time highs.
What's that mean? They've denied every rally for six years but the next one will force them to to turn bullish?
Because extreme reactions are always prone to unintended consequences. Ok?
Different arena, same madness. It's truly a mine field. I hope your acquaintance finds a different solution.
there's a really interesting phenomenon going on with individual stocks that "surprise" on earnings. I've never seen so many enormous point moves in a single earnings season and I think its a consequence of how ETF's have come to dominate the landscape. Not only do mutual funds and hedge funds jump in, but all manner of momentum based ETF's and sector ETF's are piling on. Buying begets more buying, just because there's a mandate that it must be bought.
I'm sure this is all part of a well considered Fed free money game plan, so its unlikely there will be any unintended consequences.
Obama couldn't pull out troops if they weren't there in the first place. You guys sure like to run from your own history.
He's rhetoric on this has become increasingly embarrassing, and he deserves all the heat you right wingers are bringing. But don't forget, this is all unintended consequence of your guy's Iraq invasion.
That's the beauty of this sector. No pesky valuation metrics so any slug with an online account can proclaim a target. Good luck.
This stock was off of everyone's radar, until the Teva marketing news. That collaboration validated the company and suddenly it was very under owned. It got heat, it got fund attention, it got forced buying. As the valuation rose, the passive biotech etf funds were compelled to own more and more of it. So now we have a perfect storm of technical buying enhanced by the standard free wheeling appetite for all small cap biotech.
What's next? In the absence of fresh news, down hard, probably from an almost certain secondary. Then a trading range. Congrats to anyone lucky enough to be a part of this ride.
Within the giant wedge, there's been a dozen or more recurring patterns similar to the one we're in now. It could continue for a week or two, or a news event will be used as a catalyst to force everyone temporarily out of their positions. I know you've been dialed in on that weird spy print getting tested. That's a good call, and we're close enough now.